Back to Results
First PageMeta Content
Medicine / Chemistry / Brain / Sodium valproate / Valproic acid / Valproate semisodium / Lamotrigine / Epilepsy / Pregnancy / Anticonvulsants / Mood stabilizers / Teratogens


FDA Drug Safety Communication: Valproate Anti-seizure Products Contraindicated for Migraine Prevention in Pregnant Women due to Decreased IQ Scores in Exposed Children Safety Announcement[removed]The U.S. Food and D
Add to Reading List

Open Document

File Size: 104,12 KB

Share Result on Facebook

IndustryTerm

treatment of manic episodes associated with bipolar disorder / pregnant patients taking valproate products / prevention of migraine / outpatient retail setting / derivative products / valproate products / valproate product / age taking valproate products / Migraine Prevention / adverse events involving valproate products / /

MedicalCondition

schizophrenic disorders / neural tube defects / particularly neural tube defects / spina bifida / neural tube defect / seizures / serious birth defects / episodic mood disorders / migraine / persistent seizures / Pain / migraine headaches / structural and functional birth defects / epilepsy / permanent injury / bipolar disorder / /

Organization

U.S. Food and Drug Administration / FDA / /

/

Position

physician / /

Product

Depakote ER / phenytoin / Depakene / Depacon / lamotrigine / folic acid / divalproex sodium / valproic acid / carbamazepine / valproate sodium / Depakote CP / Depakote / /

URL

http /

SocialTag